MDI Manufacturing Services

Similar documents
Partner with the Global Leader in Drug Delivery Systems

Cell Therapy Services Your Product. Our Passion.

FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS

PRAXIS. A publication by Bioengineering AG

PHARMACEUTICAL TESTING

Leader in Pharmaceutical Oral Films

Business Units contract development and manufacturing cost effective processes reliability of supply. total API solution retroviral APIs

The largest network of harmonized bio/ pharmaceutical GMP product testing labs worldwide, Eurofins BioPharma Product Testing enables companies to

Exclusive Manufacturing Solutions

KINGSMANN CARE GROUP

GxP Auditing, Remediation, and Staff Augmentation

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

GPhA Fall Technical Conference Nov 2-5, 2015 Bethesda, MD ICH M7 Guidance Overview and Current FDA Perspectives

Regulatory Starting Materials An FDA Perspective

Where Quality Meets Flexibility

3M Purification Inc. Technical and Scientific Services Global Support for the Life Science Industry. Global Expertise delivered locally

GxP Auditing, Remediation, and Staff Augmentation

ICH Q8/Q8(R)

BIOPHARMA SOLUTIONS TM Expedite Your Drug Development Program

Emerging Trends in Regulatory Outsourcing WHITE PAPER.

COMMERCIAL PRODUCT STABILITY

QbD (Quality by Design) Has industry benefited from this? WHITE PAPER.

GxP Auditing, Remediation, and Quality System Resourcing

Challenges in Getting Global Approvals for Post-approval Changes

The Role of Chemists in the FDA Drug Approval Process

APPLICATION OUTSOURCING. for life sciences

CREATING TOMORROW S SOLUTIONS BIOPHARMACEUTICALS I CONTRACT MANUFACTURING WACKER BIOTECH: THE MICROBIAL CMO

Evolution of Quality Assessments Recent Trends in FDA Queries. Mike Saleh, Pfizer Inc.

A drug development crossroad lies ahead

Starting Material Selection for Type II Drug Master Files

Key Definitions 6/16/2015

PAREXEL PARTNER PROGRAM. Broaden your reach with a partner you can trust

EU and FDA GMP Regulations: Overview and Comparison

A Global CRO STRONGER TOGETHER

Evolution of the CMC Review - ANDAs

PMDA Views on Applying Continuous Manufacturing to Pharmaceutical Products for Industry (provisional draft)

Analytical Methods Development and Validation

Speed your time to market with FDA s expedited programs

MSC - Marine Stewardship Council Consultation Document:

Industry Perspective on Manufacturing in Early Development

Risk Management in Drug Product Manufacturing with Emphasis on Batch Documentation/Execution

Pharma EXPO 6 9 November 2016 Chicago, IL

THE COMMON TECHNICAL DOCUMENT: TAKING INDIAN NDA PROCESS TOWARDS GLOBALIZATION

WHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges

DATWYLER SEALING SOLUTIONS HEALTH CARE

ICH Q11 Development & manufacture of drug substances

Vince Anicetti EVP Quality and Compliance, Coherus Biosciences West Coast PDA 20 October 2016

News Release. Even more attractive to life science and fine chemical industries. Saltigo at CPhI 2017, Frankfurt, October 24-26, 2017, Stand 111H21

Regulatory Affairs, Compliance Assurance, Quality Systems, Remediation Strategy and Support, and Strategic Consulting Services

Effective competence assurance management is as easy as itb. competence assurance

DHL THERMONET SETTING NEW STANDARDS IN TEMPERATURE CONTROLLED SHIPPING

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Identifying and Controlling CPPs and CMAs

OVERVIEW OF DRUG REGISTRATION REQUIREMENTS FOR PHARMACEUTICALS IN EMERGING MARKET

ICH Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management

Seamless Integration of ASTM E2500, Annex 15, FDA Process Validation Guideline and Chinese GMP in Large CapEx Project in China Daniel Nilsson

Regulatory perspectives on CQAs, CPPs, and Risk Analyses for Combination Products.

Industry Experience: Early Collaboration with FDA on Combination Products. Kristi Kistner, Amgen Inc. CMC Strategy Form January 26, 2015

Tim Moore Global Head, Pharmaceutical Technical Operations Biologics, Genentech a member of the Roche Group

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

Thomson Reuters Client On-boarding. An end-to-end client lifecycle management solution.

ICH Topic M 4 Q Location issues for Common Technical Document for the Registration of Pharmaceuticals for Human Use Quality Questions and Answers

Excipient Certification: Schemes and Auditable Standards - the role in Supplier Qualification

CGMP for Phase 1 INDs

Personalization Brings Results

HealthCaps. Quality our Priority

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Mapping Success for Commercial Cell Therapy Manufacturing 100% 50% 0% 100% 50% 0% 100% 50% Realization

Cambridge Commodities Ltd QUALITY MATTERS

Policy Administration Transformation

How can regulatory affairs drive greater value for the patient and for the business?

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

TIME SAVER LIFE SAVER

An Introduction to Double Dragon Consulting

ABL Europe s GMP manufacturing facility for viral vector production

Formulation Development

ENSURING QUALITY THROUGH COMPLIANCE [ COMPLIANCE ]

MIGRATING AND MANAGING MICROSOFT WORKLOADS ON AWS WITH DATAPIPE DATAPIPE.COM

Establishment of Clinical Trial Infrastructure

Information Governance for Data Integrity

Optum Intelligent EDI. Achieve higher first-pass payment rates and help your organization get paid quickly and accurately.

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Your partner in the pharmaceutical industry

Challenges and Opportunities in the Development of integrated Drug Device Combination Products CMC Strategy Forum, Tokyo, 5 December 2017

How we set specifications for impurities (including Genotoxic impurities) 24 May 2017 Elisabeth Kovacs, Apotex CSO Chemistry and Analytical Sci.

Paradigm Change in Manufacturing Operations

Introduction to CMC Regulatory Affairs


Combination products Updates Final FDA Guidance

HIKMA PHARMACEUTICALS PLC. Merrill Lynch Middle East & North Africa (MENA) Conference 13 December r 2005

Products: A Global Perspective

Boost turnaround time for faster diagnosis

Quality Risk Management

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products

Q10 PHARMACEUTICAL QUALITY SYSTEM

EXAMPLE OF VENDOR QUALIFICATION FOR IMMUNE EFFECTOR CELL PRODUCT MANUFACTURER

Taking a Leap Toward Global Supply Chain Efficiency - Part II

The Aptuit Center for Drug Discovery & Development Verona, Italy

Transcription:

MDI Manufacturing Services Presenter, Date

Who we are 3M Drug Delivery Systems is a division of 3M dedicated to working together with pharmaceutical and biotech companies to bring new and improved products to market, leveraging 3M s proprietary technology. 50-year track record in pharmaceutical product development and manufacturing. Continuing to solve problems with innovative solutions and delight customers with our quality, products, services and interactions. 2

MDI specialists from start to finish MDI pioneer, with over 50 years track record helping our customers succeed: First MDI First CFC-free MDI First single-cycle FDA review First FDA-approved* integrated dose counter available to clients. Trusted MDI manufacturer - 50% of all metered-dose inhalers worldwide utilise 3M drug delivery technology. Committed to helping customers to successfully bring cost effective, high quality, patient friendly products to market that will improve patient s lives. Global team of experts passionate about making progress possible for our clients. * In conjunction with an MDI product 3

Our MDI manufacturing approach Our responsive, flexible and collaborative approach to proactive problem solving delivers speed to market. With global capabilities and years of MDI manufacturing experience 3M helps make progress possible for customers. Operate in a safe, compliant, accountable and environmentally responsible manner while fostering an innovative environment. Lean Six Sigma methodology and cgmp compliant manufacturing make 3M the reliable choice for your Metered Dose Inhaler (MDI) products. 4

Product development and manufacturing Laboratory Pilot Facility Commercial Facility Formulation Development Process Development Scale Up Commercial Supply Your Drug Feasibility Development Scale-Up Commercial Launch/Supply Your Formulation Tech Transfer Site Qualification Commercial Supply Your product Tech Transfer Site Qualification Commercial Supply From From the complete the complete development development and manufacturing and manufacturing cycle, cycle, to specific to product specific manufacturing product needs, manufacturing 3M is fully needs, flexible 3M to is meet fully flexible your requirements. to meet your requirements. 5

Trusted manufacturer for your global MDI needs Global capacity and flexibility to produce required volumes for developed and emerging markets. Lean Six Sigma drives product and process understanding and efficiency through all processes to help customers improve competitive edge. Team of international quality and regulatory experts to ensure compliance. Corporate strength and industry relationships make supply chain management efficient and strong. Access to corporate experts helps ensure technical challenges are addressed with tangible solutions. 6

Flexible solutions to meet market changes Increased demand. Market opportunity. Failure of another supplier. 3M is equipped to meet your needs, no matter what the situation. 3M s flexible approach and customised processes Enable you to react to market opportunities or respond to increased demand Improves your product s chances for success 7

Full range of cgmp compliant services State-of-the-art fully automated Pamasol filling lines for commercial supply Analytical method development, validation, raw material and finished product testing Semi automated pilot-scale lines for toxicology and clinical supplies ICH and customer stability programs MDI pressure- and cold-filling capabilities at both pilot and commercial scale Scale-up and registration support Component manufacturing and supply Potent and controlled substance compound handling 8

Manufacturing Facilities 9

St Paul, Minnesota - USA Product and Process Development to Pilot Scale Pilot and small to intermediate commercial scale manufacturing Process configurations enable small batch sizes to conserve costly or limited API supplies Clinical and toxicological supply manufacturing Pressure- and cold-filling Single and two stage filling methods 1/3 scale of commercial batch size Potent compound handling Pamasol LB-20 Macromat DEA registrations: 2, 3 & 3N St Paul, MN Northridge, CA Hurlingham, AR Clitheroe, UK Loughborough, UK 10

Northridge, California - USA St Paul, MN Northridge, CA Clitheroe, UK Loughborough, UK Large Commercial Scale Pressure-filling Cold- filling High speed packaging Supplying tens of millions of units annually Potent compound handling and size reduction Modern quality control laboratory ISO 14001 certification DEA registrations Hurlingham, AR 11

Loughborough - UK St Paul, MN Northridge, CA Clitheroe, UK Loughborough, UK Pilot to Large Commercial Scale Cold-filling with potential to expand into pressure-filling High speed packaging Supplying tens of millions of units annually Potent compound handling and size reduction ISO 9001:2008 & ISO 13485:2003 certified manufacturing facility Hurlingham, AR 12

Hurlingham - Argentina St Paul, MN Northridge, CA Clitheroe, UK Loughborough, UK Large Commercial Scale Cold-filling millions of units annually ISO 14000 Hurlingham, AR 13

Clitheroe - UK St Paul, MN Northridge, CA Clitheroe, UK Loughborough, UK Components manufacturing Deep drawing and assembly of valves and canisters Elastomer extraction ISO 9001:2008 Hurlingham, AR 14

Manufacturing site summary Strategically located MDI filling sites with supply to global markets Commercial sites focused on quality, service, efficiency and customer relationships Pilot facilities focused on experimentation and quality optimization Capacity to meet a wide range of customer needs Global capacity: 65MM to 100MM by 2015 Capability to support product development through commercialization with a proven track record 15

Quality And Regulatory 16

Commitment to quality and improvement Undertake regular self-audits. Lean Six Sigma is embedded in manufacturing and quality processes to drive continual improvements. Commitment to total productive maintenance. Deep product and process understanding. Vast experience ensures quality by design. Operate to global standard operating procedures. Employ process analytical technology. Utilise global electronic systems for change and issue management. Accredited quality professionals. 17

Continuous quality and innovation Lean Six Sigma is embedded in 3M s everyday ways of working, making our processes robust, driving out waste and streamlining operations to contain costs Continuous stream of innovative solutions Meticulously planned, efficient product launches Shortened cycle times for new opportunities Deliver a competitive advantage for ourcustomers 18

Regulatory support Long history of success in filings worldwide (IND, ANDA, NDA, DMF). Experience ranging from sponsoring entire submissions, to preparing CMC packages, and more. Multiple active programs at different stages of development ensuring alignment with current global regulatory guidances. Our global regulatory experts ensure compliance and efficient, effective submissions. 19

Summary 20

Why choose 3M? Global capacity, flexibility and continuous problem solving approach to handle any customer request Automation for speed, efficiency and quality Reputation for delivering consistent high quality Outstanding record for compliance Complementary services including Regulatory and Analytical Services Financial stability Engineering solutions for process design and manufacturability Embedded Lean Six Sigma methodology In-house release testing Global quality systems and accredited experts Leverage corporate resources and expertise in broad technologies and innovative solutions 21

Summary From Start to Finish, 3M s expert MDI capabilities help make success possible for our customers. See how we can help take your MDI business to the next level. 22

Contact us 3M Drug Delivery Systems US: (1) 800 643 8086 UK: (44) 1509 613626 Japan: (81) 3 3709 9671 Singapore: (65) 6450 8888 China: (86) 21 22103008 Argentina: (54) 11 4469 8338 India: (91) 80 2233 1414 Thank You www.3m.com/dds 23